Key | % Net Assets |
---|---|
![]() |
5.2% |
![]() |
4.7% |
![]() |
4.6% |
![]() |
4.1% |
![]() |
81.4% |
Name | % Net Assets |
---|---|
Novartis | 5.2% |
Roche Holdings Genusscheine | 4.7% |
Banco Santander | 4.6% |
Nestle | 4.1% |
Unicredit | 3.5% |
SAP | 3.3% |
Bayer | 3.2% |
ABB | 3.1% |
Carrefour | 3.0% |
E.on | 3.0% |
No asset data available.
Date | 17-Apr-2025 |
---|---|
NAV | 227.20p |
Currency | GBP |
Change | 1.10p |
% | 0.49% |
YTD change | 9.80p |
YTD % | 4.51% |
Fund Inception | 31/01/2000 |
---|---|
Fund Manager | Thomas Digenen (UBS Asset Management Ltd) |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.38% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research